Danske Bank A S bought a new stake in shares of Baxter International Inc. (NYSE:BAX – Free Report) during the 3rd quarter, Holdings Channel reports. The fund bought 63,043 shares of the medical instruments supplier’s stock, valued at approximately $1,513,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in BAX. BlackRock Inc. purchased a new stake in Baxter International in the second quarter worth $1,744,874,000. Pzena Investment Management LLC purchased a new position in Baxter International during the 2nd quarter valued at $1,392,098,000. Equity Investment Corp purchased a new position in Baxter International during the 2nd quarter valued at $146,815,000. Bank of America Corp DE bought a new position in Baxter International in the 2nd quarter worth $132,993,000. Finally, Aberdeen Group plc lifted its position in shares of Baxter International by 16,776.9% in the 3rd quarter. Aberdeen Group plc now owns 3,743,975 shares of the medical instruments supplier’s stock worth $89,855,000 after purchasing an additional 3,721,791 shares during the period. Institutional investors own 90.19% of the company’s stock.
Baxter International Trading Down 3.0%
Shares of BAX stock opened at $25.38 on Friday. The company has a current ratio of 1.79, a quick ratio of 1.19 and a debt-to-equity ratio of 1.20. Baxter International Inc. has a 12-month low of $15.73 and a 12-month high of $30.00. The stock has a market capitalization of $13.13 billion, a P/E ratio of 13.48, a P/E/G ratio of 3.84 and a beta of 0.68. The firm’s 50 day moving average is $24.61 and its 200 day moving average is $21.79.
Baxter International (NYSE:BAX – Get Free Report) last announced its earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.06. The business had revenue of $2.98 billion during the quarter, compared to analyst estimates of $2.91 billion. Baxter International had a negative net margin of 6.23% and a positive return on equity of 16.23%. The company’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.69 EPS. Research analysts expect that Baxter International Inc. will post 2.10 earnings per share for the current year.
Baxter International Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, November 27th will be given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, November 27th. Baxter International’s payout ratio is presently -2.84%.
Wall Street Analysts Forecast Growth
Several brokerages have commented on BAX. Jefferies Financial Group reaffirmed a “hold” rating and set a $25.00 price objective on shares of Baxter International in a research report on Thursday, October 29th. Citigroup lowered their target price on Baxter International from $28.00 to $27.00 and set a “neutral” rating for the company in a research note on Monday, October 5th. Wolfe Research assumed coverage on Baxter International in a research report on Tuesday, October 20th. They set a “peer perform” rating on the stock. Wall Street Zen raised shares of Baxter International from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Finally, UBS Group raised their target price on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. One analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, Baxter International currently has a consensus rating of “Reduce” and a consensus price target of $23.27.
View Our Latest Report on Baxter International
Baxter International Company Profile
Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.
Recommended Stories
- Five stocks we like better than Baxter International
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding BAX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Baxter International Inc. (NYSE:BAX – Free Report).
Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.
